Valuation: Alpa Laboratories Limited

Market Cap 119.32Cr 1.27Cr 1.15Cr 1.06Cr 95.9L 1.81Cr 1.86Cr 13Cr 5.05Cr 64Cr 4.76Cr 4.66Cr 203.04Cr P/E 2025
11.2x
P/E 2026 6.51x
Enterprise Value -16Cr -17.08L -15.44L -14.25L -12.9L -24.35L -25.08L -1.71Cr -67.99L -8.58Cr -64.09L -62.72L -27Cr EV / Sales 2025
0.94x
EV / Sales 2026 -0.36x
Free-Float
42.71%
Yield 2025 *
-
Yield 2026 -
12/10 Alpa Laboratories Limited Approves Appointment of Radhika Biyani as an Independent Director, Effective September 30, 2026 CI
17/09 Alpa Laboratories Limited Announces Appointment of Diksha Jaswani as Company Secretary Cum Compliance Officer, Effective September 17, 2026 CI
13/08 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
23/07 Alpa Laboratories Ltd. Announces Cessation of Ms. Jyoti Jain as an Independent Director, Effective July 21, 2026 CI
08/07 Alpa Laboratories Limited Announces Resignation of Yashoda Patidar as Company Secretary and Compliance Officer, Effective July 26, 2026 CI
29/05 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
11/04 Alpa Laboratories Limited Appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer, Effective April 11, 2026 CI
25/02 Alpa Laboratories Limited Announces Resignation of Srashti Chopra as Company Secretary and Compliance Officer, Effective March 25, 2026 CI
12/02 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
13/25/13 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
01/25/01 Brookfield India Real Estate Trust announced that it expects to receive INR 10.00000015 billion in funding from a group of investors CI
28/25/28 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/25/14 Alpa Laboratories Limited Announces Change in Designation of Vitthal Kothana from Non- Executive Director to Executive Director CI
1 day-1.22%
1 week+4.82%
Current month+12.56%
1 month-0.49%
3 months-16.43%
6 months-20.27%
Current year-27.00%
1 week 51.71
Extreme 51.71
58.95
1 month 46.85
Extreme 46.85
59
Current year 46.1
Extreme 46.1
80.08
1 year 46.1
Extreme 46.1
92.5
3 years 46.1
Extreme 46.1
144.5
5 years 46.1
Extreme 46.1
144.5
10 years 11
Extreme 11
144.5
Manager TitleAgeSince
Chief Executive Officer - 28/05/2016
Director of Finance/CFO 65 -
Director TitleAgeSince
Chairman 83 -
Director/Board Member 77 01/01/1967
Director/Board Member - 28/05/2016
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%+4.82%-32.95%-35.00% 1.29Cr
-0.70%+0.66%+44.37%+138.79% 1,28000Cr
+1.11%+2.61%+46.27%+92.54% 68TCr
-0.18%-0.13%+30.77%+112.46% 52TCr
+1.14%+2.68%+40.80%+71.70% 39TCr
-0.16%-2.27%+61.57%+44.94% 36TCr
+1.11%-0.03%+28.96%+60.05% 30TCr
+0.24%-0.67%+3.45%+38.06% 29TCr
-0.22%-2.39%+38.00%+74.73% 25TCr
-1.05%-3.74%+37.03%+121.22% 21TCr
Average +0.14%+0.15%+29.83%+71.95% 43TCr
Weighted average by Cap. +0.46%+0.20%+39.59%+97.32%

Financials

2025 2026
Net sales 112.45Cr 1.2Cr 1.08Cr 99.85L 90.38L 1.71Cr 1.76Cr 12Cr 4.76Cr 60Cr 4.49Cr 4.39Cr 191.35Cr 105.81Cr 1.13Cr 1.02Cr 93.95L 85.04L 1.6Cr 1.65Cr 11Cr 4.48Cr 57Cr 4.22Cr 4.13Cr 180.05Cr
Net income 20Cr 20.75L 18.76L 17.32L 15.67L 29.58L 30.47L 2.08Cr 82.6L 10Cr 77.86L 76.2L 33Cr 15Cr 15.97L 14.44L 13.33L 12.06L 22.76L 23.45L 1.6Cr 63.57L 8.02Cr 59.92L 58.65L 26Cr
Net Debt -112.69Cr -1.2Cr -1.08Cr -1Cr -90.57L -1.71Cr -1.76Cr -12Cr -4.77Cr -60Cr -4.5Cr -4.4Cr -191.75Cr -135.37Cr -1.44Cr -1.3Cr -1.2Cr -1.09Cr -2.05Cr -2.11Cr -14Cr -5.73Cr -72Cr -5.4Cr -5.29Cr -230.36Cr
Projected Income Statement - Annual - Alpa Laboratories Limited
Logo Alpa Laboratories Limited
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Employees
457
Date Price Change Volume
12/26/12 ₹56.71 -1.22% 5,774
11/26/11 ₹57.41 +1.47% 7,290
09/26/09 ₹56.58 +1.16% 27,113
08/26/08 ₹55.93 +4.08% 11,206
06/26/06 ₹53.74 -1.32% 7,971
  1. Stock Market
  2. Stocks
  3. ALPA Stock